PARIS--(BUSINESS WIRE)--PK MED, a biotechnology company developing injectable smart implants for drug release in rheumatology and cell homing for bone marrow transplantation, today announced a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results